Samay Sappal, MD
Urology · Suffolk, VANPI 1447783071
Payments from drug & device makers
Across 32 payments — averaging $39.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$615
- Medtronic$151
- Bayer$113
- Innovation Technologies Inc$86
- C. R. Bard, Inc. & Subsidiaries$51
- Blue Earth Diagnostics$50
- plus $209 from 9 others
What the payments were for
- Food & beverage$1,274100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 12 | $615 |
| Medtronic | 2 | $151 |
| Bayer | 5 | $113 |
| Innovation Technologies Inc | 2 | $86 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $51 |
| Blue Earth Diagnostics | 1 | $50 |
| Axonics, Inc. | 1 | $41 |
| Boston Scientific | 1 | $36 |
| Tempus AI, Inc | 1 | $25 |
| Endo USA, Inc. | 1 | $23 |
| Accord Healthcare, Inc. | 1 | $19 |
| Procept Biorobotics Corporation | 1 | $19 |
| Antares Pharma, Inc. | 1 | $17 |
| Laborie Medical Technologies Corp. | 1 | $16 |
| Novartis | 1 | $14 |
How this compares
$1,274 in reported general payments places this provider in the 35th percentile of 300 urology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 27 | $29,454 |
| Tamsulosin Hcl | 542 | $6,572 |
| Silodosin | 64 | $5,034 |
| Finasteride | 342 | $4,485 |
| Tadalafil | 15 | $2,628 |
| Oxybutynin Chloride ErOxybutynin Chloride | 72 | $1,673 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 142 | $1,118 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 41 | $784 |
| Dutasteride | 18 | $455 |
| Cefdinir | 21 | $327 |
| Oxybutynin Chloride | 62 | $260 |
| Fluconazole | 16 | $239 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 45 | $225 |
| Levofloxacin | 68 | $196 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $161 |
Paid to pharmacies, not to this prescriber.
Other urology in Suffolk
- Patrick WhelanSuffolk$114K
- Akinwumni Ojo-CaronsSuffolk$22K
- Robert GivenVirginia Beach$8.7M
- Michael WilliamsVirginia Beach$2.7M
- Michael FabrizioVirginia Beach$1.6M
- Gregg EureVirginia Beach$1.5M
- Nilay GandhiWoodbridge$1.3M
- Jessica DelongVirginia Beach$644K
- Eugene KramolowskyRichmond$594K
- Nicolas OrtizCharlottesville$331K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.